Russia has started producing CoviVac, its third vaccine against COVID-19.
The new vaccine will soon be made available for use in its regions, though phase three trials are still under way, officials said on Thursday.
The most well-known Russian coronavirus vaccine is Sputnik V. Moscow has also given emergency approval to two shots, EpiVacCorona and CoviVac.
"The third Russian vaccine is entering civilian circulation and will appear in the regions in the coming days," the Science and Higher Education Ministry said in a statement.
The Chumakov Centre plans to produce up to 10 million doses of the vaccine a year, the ministry said.
Science Minister Valery Falkov said that phase three trials of the vaccine had begun, the Interfax news agency reported.
The Chumakov Centre's director said phase three trials would be completed within half a year, Interfax reported.
Venezuela quake death toll nears 3,000 as rescue effort winds down
Eight injured in New York shooting
Trump appears on National Mall for July 4 speech after storm-related delay
Qatar says all maritime activities will resume immediately
St. Petersburg region port, oil terminal hit in Ukrainian drone attack
Thousands protest in Germany as far-right AfD sets sights on power
Trump extols America, rails at communism in US 250th celebration
Zelenskyy denies Russian capture of key eastern city Kostiantynivka
